Two Companies Hit With FDA Warning Letters for Selling Unapproved and Misbranded Drugs for COVID-19

The FDA has accused two overseas companies of selling unapproved and misbranded drugs for COVID-19 to U.S. customers over the internet.
Source: Drug Industry Daily